Puterizumab

DRUG2 trials

Sponsors

Sir Runrun Shaw Hospital Affiliated to Zhejiang University School of Medicine, Sir Run Run Shaw Hospital

Conditions

Non small cell lung cancerNon-Small-Cell Lung Cancer

Phase 2

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

Not yet recruitingNCT06434740

Sir Run Run Shaw HospitalNon-Small-Cell Lung Cancer

Start: 2024-06-01End: 2027-12-30Target: 37Updated: 2024-05-30

The Efficacy and Safety of Stereotactic Radiotherapy Combined with Puterizumab in Non Small Cell Lung Cancer with Intrapulmonary Metastasis:A Phase II Prospective Single Arm Clinical Study

Active, not recruitingChiCTR2400085132

Sir Runrun Shaw Hospital Affiliated to Zhejiang University School of MedicineNon small cell lung cancer

Start: 2024-06-01Updated: 2024-06-03